한국임상수의학회지 (Journal of Veterinary Clinics)

  • 제37권3호
  • /
  • Pages.141-144
  • /
  • 2020
  • /
  • 1598-298X(pISSN)
  • /
  • 2384-0749(eISSN)
한국임상수의학회 (The Korean Society of Veterinary Clinics)
권호 표지
DOI QR코드

DOI QR Code

Efficacy of 10-Injection Induced Modified Rush Immunotherapy in Dogs with Atopic Dermatitis

  • Kim, Hyun-Tae (College of Veterinary Medicine & Research Institute of Veterinary Medicine, Chungnam National University) ;
  • Lee, Wang-Hui (College of Veterinary Medicine & Research Institute of Veterinary Medicine, Chungnam National University) ;
  • Park, Seong-Jun (College of Veterinary Medicine & Research Institute of Veterinary Medicine, Chungnam National University)
  • 투고 : 2019.08.27
  • 심사 : 2019.10.21
  • 발행 : 2020.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Modified rush immunotherapy (IT), by combination of rush IT and conventional IT, provides a faster method to reach maintenance dose, leading to higher patient adherence when compared with conventional IT, decreasing systemic adverse reactions when compared with a standard rush IT. Ten atopic dogs of this study include fulfillment of Favrot's criteria. Offending allergens were identified by the use of IDST. During the induction period, the dogs were received a total of 10 injections. Five injections were administrated every 30 minutes in a day with gradually increasing amounts and concentrations of allergens, and the last 5 injections were administered every 3 days. The efficacy of 10-injection induced mRIT was assessed using the canine atopic dermatitis extent and severity index (CADESI). During maintenance period, reduction rate from baseline scores varied between 3.2% and 60.9% and the after 6 months of therapy for CADESI-03 score in 6 of the 10 dogs. Adverse reactions were not observed in these dogs during induction period by mRIT with 10 injections. Based on these results, our modified rush IT protocol is considered to be a useful protocol to treat canine atopic dermatitis.

키워드

참고문헌

  1. Angarano DW, MacDonald JM. Immunotherapy in canine atopy. In: Current Veterinary Therapy, Vol. XI. Philadelphia: Saunders. 1991: 505-508.
  2. Favrot C, Steffan J, Seewald W, Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol 2010; 21: 23-31. https://doi.org/10.1111/j.1365-3164.2009.00758.x
  3. Griffin CE, Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Vet Immunol Immunopathol 2001; 81: 363-383. https://doi.org/10.1016/S0165-2427(01)00348-8
  4. Hillier A, DeBoer DJ. The ACVD task force on canine atopic dermatitis (XVII): intradermal testing. Vet Immunol Immunopathol 2001; 81: 289-304. https://doi.org/10.1016/S0165-2427(01)00313-0
  5. Lee WH, Park SJ. Efficacy of modified rush allergen-specific immunotherapy on canine atopic dermatitis. J Vet Clin 2017; 34: 245-248. https://doi.org/10.17555/jvc.2017.08.34.4.245
  6. Mueller RS, Bettenay SV. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis. Am J Vet Res 2001; 62: 307-310. https://doi.org/10.2460/ajvr.2001.62.307
  7. Mueller RS, Fieseler KV, Zabel S, Rosychuk RAW. Conventional and rush allergen-specific immunotherapy in the treatment of canine atopic dermatitis. In: Advances in Veterinary Dermatology, Vol. 5. Oxford: Blackwell publishing. 2005: 60-69.
  8. Nuttall J, Thoday KL, van den Broe AH, Jackson HA, Sture GH, Halliwell REW. Retrospective survey of allergen immunotherapy in canine atopy. Vet Rec 1998; 143: 139-142. https://doi.org/10.1136/vr.143.5.139
  9. Olivry T, DeBoer DJ, Griffin CE, Halliwell RE, Hill PB, Hillier A, Marsella R, Sousa CA. The ACVD task force on canine atopic dermatitis: forewords and lexicon. Vet Immunol Immunopathol 2001; 81: 143-146. https://doi.org/10.1016/S0165-2427(01)00343-9
  10. Olivry T, Marsella R, Iwasaki T, Mueller R. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 2007; 18: 78-86. https://doi.org/10.1111/j.1365-3164.2007.00569.x
  11. Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review on the pharmacotherapy of canine atopic dermatitis. Vet Dermatol 2003; 14: 121-146. https://doi.org/10.1046/j.1365-3164.2003.00335.x
  12. Park S, Ohya F, Yamashita K, Iwasaki T. Comparison of response to immunotherapy by intradermal skin test and antigenspecific IgE in canine atopy. J Vet Med Sci 2000; 62: 983-988. https://doi.org/10.1292/jvms.62.983
  13. Patterson R, Harris KE. Rush immunotherapy in a dog with severe ragweed and grass pollen allergy. Ann Allergy Asthma Immunol 1999; 83: 213-216. https://doi.org/10.1016/S1081-1206(10)62642-7
  14. Reedy LM, Miller WH, Willemse T. Immunotherapy. In: Allergic skin disease of dog and cat, 2nd ed. Philadelphia: WB Saunders. 1997: 116-149.
  15. Rosser EJ. Aqueous hyposensitization in the treatment of canine atopic dermatitis: a retrospective study of 100 cases. In: Advances in Veterinary Dermatology, Vol. 3. Boston: Butterworths/Heinemann. 1998: 169-176.
  16. Scott DW, Miller WH, Griffin CE. Skin immune system and allergic skin disease. In: Muller and Kirk's Small animal dermatology, 6th ed. Philadelphia: WB Saunders. 2001; 597-601.
  17. Sharkey P, Portnoy J. Rush immunotherapy: experience with a one-day schedule. Ann Allergy Asthma Immunol 1996; 76: 175-180. https://doi.org/10.1016/S1081-1206(10)63419-9
  18. Schwartzman RM, Mathis L. Immunotherapy for canine atopic dermatitis: efficacy in 125 atopic dogs with vaccine formulation based on ELISA allergy testing. J Vet Allergy Clin Immunol 1997; 5: 144-152.